Cyclic Variation of Spectral Parameters for the Differentiation of Atrial Myocardium Before and Immediately Following Radiofrequency Ablation.


Journal

Ultrasonic imaging
ISSN: 1096-0910
Titre abrégé: Ultrason Imaging
Pays: England
ID NLM: 7909167

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 14 9 2021
medline: 29 10 2021
entrez: 13 9 2021
Statut: ppublish

Résumé

Radiofrequency ablation (RFA) is a common treatment of atrial fibrillation. However, current treatment is associated with a greater than 20% recurrence rate, in part due to inadequate monitoring of tissue viability during ablation. Spectral parameters, in particular cyclic variation of integrated backscatter (CVIB), have shown promise as early indicators of myocardial recovery from ischemia. Our aim was to demonstrate the use of spectral parameters to differentiate atrial myocardium before and after radiofrequency ablation. An AcuNav 10 F catheter was used to collect radiofrequency signals from the posterior wall of the left atrium of patients before and immediately after RFA for AF. The normalized power spectrum was obtained and three spectral parameters (integrated backscatter [IB], slope, and intercept) were extracted across two continuous heart cycles. Parameters were gated for ventricular end-diastole and compared before and after ablation. Additionally, the cyclic variation of each of these three parameters was generated as an average of the variation across the two recorded heart cycles. Data from 14 patients before and after ablation demonstrated a significant difference in the magnitude of the cyclic variation of integrated backscatter (9.0 vs. 6.0 dB,

Identifiants

pubmed: 34510970
doi: 10.1177/01617346211046314
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-307

Auteurs

Scott Anjewierden (S)

Community Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.

Oussama M Wazni (OM)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.

D Geoffrey Vince (DG)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Department of Biomedical Engineering, Cleveland Clinic, Cleveland, OH, USA.

Mohamed Kanj (M)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.

Walid Saliba (W)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.

Russell J Fedewa (RJ)

Department of Biomedical Engineering, Cleveland Clinic, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH